PhAST was founded by Roman Stocker, Kwangmin Son in 2017.

How much funding has PhAST raised?

PhAST has disclosed $18.6M raised across 3 rounds.

Where is PhAST headquartered?

PhAST is headquartered in Boston, US.

PhAST

Boston, US · Founded 2017 · Delaware corporation

PhAST develops AI and machine learning imaging technology for infectious disease diagnostics, using single-cell imaging and a cloud-based platform to address antibiotic resistance. Its platform provides clinical decision support for doctors, workflow tools for hospitals, and drug development support for pharmaceutical companies.

AI & Machine Learning Biotech Digital Health

Founders & leadership

PhAST was founded in 2017 by Roman Stocker and Kwangmin Son.

Roman StockerCo-founder

Kwangmin SoninCo-founder

Reported raises · per SEC filings

Form D private placements

$18.6M disclosed across 3 rounds · 2021–2025

▶$3.5MraisedApr 2025 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Roman StockerExecutive Officer, Director
Kwangmin SonExecutive Officer, Director

Offering amount: $8M
Amount sold: $3.5M
First sale: Apr 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$4.4MraisedDec 2022 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Roman StockerExecutive Officer, Director
Kwangmin SonExecutive Officer, Director

Offering amount: $14M
Amount sold: $4.4M
First sale: Dec 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$10.8MraisedOct 2021 · 15 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Kwangmin SonExecutive Officer, Director
Roman StockerExecutive Officer, Director

Offering amount: $19M
Amount sold: $10.8M
First sale: Oct 2021
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Intercept Pharmaceuticals4 shared keywordsIntercept Pharma develops therapeutics for rare liver diseases, focusing on cholestatic pruritus in Primary Biliary Cholangitis patients through IBAT inhibitor programs and bile acid biology research.

Companies competing with PhAST for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

PhAST Raises $3.47M Series B to Revolutionize Rapid Pathogen Diagnostics with Single-Cell Imaging Advances | SignalBasetrysignalbase.com · May 2025

News - PhAST Corp.phast.ai · Feb 2020

Frequently asked questions

What does PhAST do?: PhAST develops AI and machine learning imaging technology for infectious disease diagnostics, using single-cell imaging and a cloud-based platform to address antibiotic resistance. Its platform provides clinical decision support for doctors, workflow tools for hospitals, and drug development support for pharmaceutical companies.
Who founded PhAST?: PhAST was founded by Roman Stocker, Kwangmin Son in 2017.
How much funding has PhAST raised?: PhAST has disclosed $18.6M raised across 3 rounds.
Where is PhAST headquartered?: PhAST is headquartered in Boston, US.